These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24224539)

  • 1. Therapeutic cancer vaccines: a long and winding road to success.
    Baxevanis CN; Papamichail M; Perez SA
    Expert Rev Vaccines; 2014 Jan; 13(1):131-44. PubMed ID: 24224539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
    Banday AH; Jeelani S; Hruby VJ
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines in the new era of cancer immunotherapy.
    Knutson KL; Mittendorf EA
    Vaccine; 2015 Dec; 33(51):7376. PubMed ID: 26432907
    [No Abstract]   [Full Text] [Related]  

  • 4. Systems vaccinology for cancer vaccine development.
    Petrizzo A; Tagliamonte M; Tornesello M; Buonaguro FM; Buonaguro L
    Expert Rev Vaccines; 2014 Jun; 13(6):711-9. PubMed ID: 24766452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination strategies for solid tumors--fundamentals, limitations, and recent results].
    Atanackovic D
    Ther Umsch; 2004 Jun; 61(6):389-96. PubMed ID: 15253165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized cancer neoantigen vaccines come of age.
    Chu Y; Liu Q; Wei J; Liu B
    Theranostics; 2018; 8(15):4238-4246. PubMed ID: 30128050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in cancer vaccines.
    Buonaguro L; Aurisicchio L; Buonaguro FM; Ciliberto G
    Expert Rev Vaccines; 2013 Oct; 12(10):1109-10. PubMed ID: 24124872
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for the future of prostate cancer vaccines.
    Madan RA; Gulley JL
    Expert Rev Vaccines; 2016; 15(3):271-4. PubMed ID: 26560494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poxviruses as vectors for cancer immunotherapy.
    Kwak H; Hörig H; Kaufman HL
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):161-8. PubMed ID: 12669450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
    Berzofsky JA; Wood LV; Terabe M
    Expert Rev Vaccines; 2013 Oct; 12(10):1115-8. PubMed ID: 24124874
    [No Abstract]   [Full Text] [Related]  

  • 12. Various ways to improve whole cancer cell vaccines.
    Cicchelero L; de Rooster H; Sanders NN
    Expert Rev Vaccines; 2014 Jun; 13(6):721-35. PubMed ID: 24758597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.
    Bot A; Marincola F; Smith KA
    Expert Rev Vaccines; 2013 Oct; 12(10):1219-34. PubMed ID: 24099049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy].
    Ikeda H; Shiku H
    Nihon Rinsho; 2012 Dec; 70(12):2043-50. PubMed ID: 23259373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines for cancer.
    Boyd D; Hung CF; Wu TC
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization.
    Kogan Y; Halevi-Tobias K; Elishmereni M; Vuk-Pavlović S; Agur Z
    Cancer Res; 2012 May; 72(9):2218-27. PubMed ID: 22422938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for tumor prevention: a pipe dream?
    Forni G
    J Infect Dev Ctries; 2015 Jul; 9(6):600-8. PubMed ID: 26142669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical vaccines against mammary carcinoma.
    Lollini PL; Cavallo F; De Giovanni C; Nanni P
    Expert Rev Vaccines; 2013 Dec; 12(12):1449-63. PubMed ID: 24195482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.